GPR55 and non-small cell lung carcinoma: Downregulation of miR-675-5p has been shown in non-small-cell lung cancer (NSCLC), which is correlated with TNM stage and lymph node metastasis of this disease [113], and may play a role in the upregulation of GPR55 expression in NSCLC.